Molecular Partners AG
MOLN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001745114
No open-market purchases or sales by Molecular Partners AG insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Molecular Partners AG as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- +15 vs. Q1 2021
- Shares held
- 1.72M
- +1.72M vs. Q1 2021
- Total value
- $35.1M
- +$35.1M vs. Q1 2021
- New holders
- 15
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MOLN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $13.8M |
| Q1 2026 | 4 | $14.2M |
| Q4 2025 | 6 | $15.6M |
| Q3 2025 | 6 | $13.3M |
| Q2 2025 | 6 | $13.7M |
| Q1 2025 | 6 | $14.2M |
| Q4 2024 | 5 | $17.0M |
| Q3 2024 | 5 | $4.20M |
| Q2 2024 | 8 | $6.18M |
| Q1 2024 | 8 | $3.83M |
| Q4 2023 | 8 | $3.91M |
| Q3 2023 | 7 | $3.91M |
| Q2 2023 | 7 | $5.73M |
| Q1 2023 | 6 | $5.60M |
| Q4 2022 | 8 | $5.99M |
| Q3 2022 | 8 | $6.17M |
| Q2 2022 | 8 | $5.93M |
| Q1 2022 | 8 | $27.6M |
| Q4 2021 | 9 | $22.4M |
| Q3 2021 | 9 | $27.7M |
| Q2 2021 | 15 | $35.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Molecular Partners AG; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 23 | $0 | 0.00% | +23 | New |
| Westchester Capital Management, LLC | 1,000 | $20.0K | 0.00% | +1,000 | New |
| Morgan Stanley | 1,201 | $25.0K | 0.00% | +1,201 | New |
| Old Mission Capital LLC | 14,781 | $303.0K | 0.01% | +14,781 | New |
| Capstone Investment Advisors, LLC | 28,741 | $589.0K | 0.01% | +28,741 | New |
| Caas Capital Management LP | 60,000 | $1.23M | 0.07% | +60,000 | New |
| Millennium Management LLC | 68,145 | $1.39M | 0.00% | +68,145 | New |
| Marshall Wace North America L.P. | 96,499 | $1.97M | 0.01% | +96,499 | New |
| Artal Group S.A. | 100,000 | $2.05M | 0.05% | +100,000 | New |
| Hound Partners, LLC | 121,247 | $2.48M | 0.12% | +121,247 | New |
| BlackRock Inc. | 165,038 | $3.38M | 0.00% | +165,038 | New |
| Tudor Investment Corp Et Al | 175,033 | $3.59M | 0.07% | +175,033 | New |
| Federated Hermes, Inc. | 235,294 | $4.80M | 0.01% | +235,294 | New |
| Monashee Investment Management LLC | 250,000 | $5.12M | 0.61% | +250,000 | New |
| Suvretta Capital Management, LLC | 400,000 | $8.20M | 0.12% | +400,000 | New |